Amplify Etf Performance
| GERM Etf | USD 19.16 0.12 0.62% |
The etf shows a Beta (market volatility) of 0.0724, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Amplify's returns are expected to increase less than the market. However, during the bear market, the loss of holding Amplify is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Amplify has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the ETF investors. ...more
| In Threey Sharp Ratio | -0.41 |
Amplify |
Amplify Relative Risk vs. Return Landscape
If you would invest 1,931 in Amplify on August 31, 2024 and sell it today you would lose (15.00) from holding Amplify or give up 0.78% of portfolio value over 90 days. Amplify is currently does not generate positive expected returns and assumes 0.248% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of etfs are less volatile than Amplify, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Amplify Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amplify's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Amplify, and traders can use it to determine the average amount a Amplify's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.7843
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GERM |
Estimated Market Risk
| 0.25 actual daily | 2 98% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.78 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Amplify is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amplify by adding Amplify to a well-diversified portfolio.
Amplify Fundamentals Growth
Amplify Etf prices reflect investors' perceptions of the future prospects and financial health of Amplify, and Amplify fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Amplify Etf performance.
| Total Asset | 21.76 M | |||
About Amplify Performance
By examining Amplify's fundamental ratios, stakeholders can obtain critical insights into Amplify's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Amplify is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
-listed equity securities or depositary receipts of companies that perform research, development, and commercialization of treatments or vaccines for infectious diseases or engage in the research, development, manufacturing, and provision of biological tests for patients. Etfmg Treatments is traded on NYSEARCA Exchange in the United States.| Amplify is not yet fully synchronised with the market data | |
| Amplify generated a negative expected return over the last 90 days | |
| The fund created three year return of -24.0% | |
| Amplify retains 99.49% of its assets under management (AUM) in equities |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
The market value of Amplify is measured differently than its book value, which is the value of Amplify that is recorded on the company's balance sheet. Investors also form their own opinion of Amplify's value that differs from its market value or its book value, called intrinsic value, which is Amplify's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amplify's market value can be influenced by many factors that don't directly affect Amplify's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amplify's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amplify is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amplify's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.